Drug Class
MEK inhibitor
Type
ingredient
Active Ingredient
selumetinib
📋Overview
Selumetinib is a targeted therapy drug that inhibits MEK enzymes, which are part of a signaling pathway involved in cell growth and division. It is primarily associated with certain types of cancers, particularly those with genetic mutations affecting the MAPK/ERK pathway. Selumetinib has been studied in conditions such as neurofibromatosis type 1 and some solid tumors. Its use is based on its ability to interfere with abnormal cell signaling linked to tumor development.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for selumetinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.